QOL Medical LLC
Frank DeCosta III is a seasoned professional in the pharmaceutical and medical sales industry, currently serving as a Senior Rare Disease Specialist and Northeast Regional Field Trainer at QOL Medical LLC since October 2022, focusing on Congenital Sucrase-Isomaltase Deficiency. Prior experience includes a role as Senior Neuroscience Area Manager Long Term Care at Avanir Pharmaceuticals, where responsibilities centered on managing NUEDEXTA for pseudobulbar affect. Frank has also held positions at OPKO Health as a Renal Sales Specialist, and at Allergan in various capacities, including Senior Medical Sales Representative. Experience at Actavis plc and Forest Laboratories includes roles in CNS, Pain Management, and specialty sales. Frank's career began at Enterprise Rent-A-Car, where management and training were key responsibilities. Frank holds educational credentials from Johnson and Wales University and Assumption College.
This person is not in any offices
QOL Medical LLC
OL Medical is a specialty biopharmaceutical company dedicated to improving the quality of life for patients with rare diseases, for their families, and for the physicians and caregivers who support them.QOL Medical is a patient-centric company founded in 2003 to focus on the acquisition and commercialization of orphan products in underservedmarkets. QOL Medical ensures an expanded clinical awareness and patient access for improved quality of life in the treatment of rare and orphan diseases. The Company currently markets two FDA-approved products: Sucraid® (sacrosidase) Oral Solution and Ethamolin® (Ethanolamine Oleate) Injection, 5%.QOL Medical, in its commitment to assuring safe and effective products for our customers, uses validated procedures through audited and approved vendors for manufacturing, testing, and distribution. Additionally, QOL Medical has procedures for product monitoring, customer complaints, investigations into nonconformities, and change control.